20969 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Cytokines; Lymphokines; Interferons; Interleukins [IL] IL-6
METHODS AND SYSTEMS FOR IMPROVED NUCLEIC ACID DELIVERY VIA ULTRASOUND
#2System and Method for the Production, Formulation and Use of Conditioned Media, Cultured Cells and the Factors Included Therein
#3Recombinant Viral Particle for Gene and/or Cellular Therapy
#4ALPHAVIRUS T CELL EPITOPES, MEGAPOOLS AND USES THEREOF
#5METHOD OF MANUFACTURING DIABETIC FOOT PATIENT-SPECIFIC DERMAL REGENERATION SHEET AND DIABETIC FOOT PATIENT-SPECIFIC DERMAL REGENERATION SHEET MANUFACTURED USING THE SAME
#6COMBINATION ANTI-4-1BB IMMUNOTHERAPY, RADIOTHERAPY, AND B CELL ACTIVATION THERAPY
#7ENGINEERED BACTERIAL THERAPEUTICS FOR THE TREATMENT OF GASTROINTESTINAL DISEASE
#8METHODS OF PREPARATION OF SECRETOMES, AND USES THEREOF
#9METHODS FOR THE TREATMENT OF DIABETES-ASSOCIATED AUTONOMIC NEUROPATHY
#10PRODUCTION OF ENHANCED STEM CELL-BASED EXOSOMES AND USES IN SCAR TISSUE PREVENTION AND TREATMENT
#11THERAPEUTIC COMPOSITION AND METHOD COMBINING MULTIPLEX IMMUNOTHERAPY WITH CANCER VACCINE FOR THE TREATMENT OF CANCER
#12Modified Cell Expansion and Uses Thereof
#13NOVEL THERAPEUTIC COMPRISING A SECRETOME FROM MESENCHYMAL STEM CELLS OF UMBILICORD TISSUE OR WHARTON'S JELLY
#14PRODUCTION OF ENHANCED STEM CELL-BASED EXOSOMES AND USES IN SCAR TISSUE PREVENTION AND TREATMENT
#15METHOD FOR TREATING INFECTIOUS DISEASE
#16NEUROPROTECTIVE COMPOSITIONS AND USE THEREOF
#17METHODS AND COMPOUNDS FOR THE TREATMENT OR PREVENTION OF SEVERE INFLUENZA
#18OXAZAPHOSPHORINE ANTIBODY DRUG CONJUGATES AND METHODS OF USE
#19SALMONELLA ENGINEERED FOR NONTOXIC COLONIZATION OF TUMORS
#20Systems and Methods for Angiogenic Treatment in Wound Healing
#21METHODS AND COMPOSITIONS FOR INDUCING DIFFERENTIATION OF HUMAN BROWN ADIPOCYTE PROGENITORS
#22METHODS FOR PREVENTING AND TREATING CHRONIC PAIN
#23METHODS OF USE OF MODULATORS TO IMPROVE NERVE REGENERATION
#24METHODS OF TREATING AGE-RELATED FRAILTY WITH INTERLEUKIN-6
#25ISOLATION AND USE OF HUMAN LYMPHOID ORGAN-DERIVED SUPPRESSIVE STROMAL CELLS
#26COMPOSITIONS AND METHODS OF CELLULAR IMMUNOTHERAPY
#27BACTERIAL TARGETING VECTOR CARRYING CYTOKINE OR POLYNUCLEOTIDE THEREOF AND USE THEREOF IN TUMOR TREATMENT
#28METHODS AND COMPOSITIONS FOR PRODUCING AN ADENOVIRUS VECTOR FOR USE WITH MULTIPLE VACCINATIONS
#29METHODS AND COMPOSITIONS FOR PRODUCING AN ADENOVIRUS VECTOR FOR USE WITH MULTIPLE VACCINATIONS
#30METHODS FOR TREATING COVID-19
#31STEM CELL CONDITIONED MEDIA FOR CLINICAL AND COSMETIC APPLICATIONS
#32PHARMACEUTICAL AND COSMETIC COMPOSITIONS COMPRISING SECRETOMES
#33PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF POST-SURGICAL PAIN
#34Coronavirus T Cell Epitopes and Uses Thereof
#35NANOPARTICLE COMPLEX WITH DEFINED SIZES
#36CRANIAL NEUROPATHY THERAPEUTIC AGENT CONTAINING CULTURE SUPERNATANT FOR UMBILICAL CORD BLOOD MONOCYTIC CELLS
#37Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#38Recombinant Viral Particle for Gene and/or Cellular Therapy
#39Methods for treating COVID-19
#40Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#41METHODS TO INCREASE THE SENSITIVITY AND REVERSING THE RESISTANCE TO DRUGS
#42METHODS AND COMPOSITIONS FOR INDUCING DIFFERENTIATION OF HUMAN BROWN ADIPOCYTE PROGENITORS
#43Methods and compounds for the treatment or prevention of severe influenza
#44Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#45Therapeutic composition and method combining multiplex immunotherapy with cancer vaccine for the treatment of cancer
#46CELL CULTURE FOR TREATING DISEASE IN THE LOWER LIMBS
#47FORMULATION AND TREATMENT FOR OPHTHALMIC DISORDERS
#48COMPOSITIONS AND METHODS OF MODULATING ENDOCHONDRAL OSSIFICATION AND BONE FORMATION
#49Monocyte compositions and methods for the treatment of infectious disease
#50KAPPA MYELOMA ANTIGEN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#51Compositions and Methods for Promoting Angiogenesis in the Eye
#52Combination Of Local And Systemic Immunomodulative Therapies For Enhanced Treatment of Cancer
#53COMBINED USE OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS AND HEMATOPOIETIC GROWTH FACTORS FOR TREATING HEMATOPOIETIC DISEASES
#54METHOD OF MANUFACTURING DIABETIC FOOT PATIENT-SPECIFIC DERMAL REGENERATION SHEET AND DIABETIC FOOT PATIENT-SPECIFIC DERMAL REGENERATION SHEET MANUFACTURED USING THE SAME
#55METHOD FOR PREPARING AND DELIVERING BISANTRENE FORMULATIONS
#56ADDITIVE FOR MEDIUM FOR PROMOTING PRODUCTION OF PARACRINE FACTOR
#57METHODS FOR TREATMENT OF MICROBIAL DISORDERS
#58ANTI-IL-6 ANTIBODIES FOR THE TREATMENT OF ORAL MUCOSITIS
#59NEUROPROTECTIVE COMPOSITIONS AND USE THEREOF
#60METHODS FOR GENERATING MACROPHAGES WITH ENHANCED CANCER PHAGOCYTOSIS
#61Particles for delivery of proteins and peptides
#62PAIN RESPONSE MEDIATOR COMPOSITIONS AND METHODS FOR MAKING AND USING SAME
#63BIO-MIMETIC FORMULATION
#64Modified cell expansion and uses thereof
#65SKIN OINTMENT FOR TREATING LABIA MINORA SKIN
#66MANNOSE-6-PHOSPHATE BEARING PEPTIDES FUSED TO LYSOSOMAL ENZYMES
#67USES OF PD-1/PD-L1 INHIBITORS AND/OR CTLA-4 INHIBITORS WITH A BIOLOGIC CONTAINING MULTIPLE CYTOKINE COMPONENTS TO TREAT CANCER
#68Methods for administering STING agonists
#69Pharmaceutical compositions comprising oncostatin m (OSM) antagonist derivatives and methods of use
#70System and Method for the Production, Formulation and Use of Conditioned Media, Cultured Cells and the Factors Included Therein
#71Catalyst for the regeneration of tissues and related method for making it
#72Glaucoma treatment
#73Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#74Systems and methods for angiogenic treatment in wound healing
#75ANTI-IL-6 ANTIBODIES FOR THE TREATMENT OF ANEMIA
#76Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer
#77Methods of treating a neurological or psychiatric disorder
#78Combination of an anti-CD16A antibody with a cytokine
#79COMPOSITIONS AND METHODS FOR TREATING AND REPAIRING TENDONS
#80Compositions for biological systems and methods for preparing and using the same
#81Methods and compounds for the treatment or prevention of severe influenza
#82Compositions and methods of modulating endochondral ossification and bone formation
#83Packaging cell for making a pseudotyped lentivirus
#84Modified cell expansion and uses thereof
#85Re-directed immunotherapy
#86Mesenchymal stem cells expressing anti-inflammatory cytokines and methods of use
#87BIO-MIMETIC FORMULATION
#88METHOD TO IMPROVE THE EFFECTIVENESS OF ANTI-CANCER THERAPIES BY EXPOSING CANCER CELLS TO AN INFLAMMATORY STIMULUS PRIOR TO TREATMENT
#89Postpartum cells derived from placental tissue, and methods of making and using the same
#90Composition for treating chronic pulmonary disease, comprising exosome derived from thrombin-treated stem cell
#91Compositions and methods of cellular immunotherapy
#92Methods for generating macrophages with enhanced cancer phagocytosis
#93Methods for reducing severity of pulmonary fibrosis
#94ANTI-IL-6 ANTIBODIES FOR THE TREATMENT OF ORAL MUCOSITIS
#95System and method for treating inflammation
#96Methods for inducing migration by dendritic cells and an immune response
#97Soft tissue repair and regeneration using postpartum-derived cells and cell products
#98METHODS AND COMPOSITIONS USING AMPK ACTIVATORS FOR PHARMACOLOGICAL PREVENTION OF CHRONIC PAIN
#99Early cancer detection and enhanced immunotherapy
#100Neurotherapeutic nanoparticle compositions comprising leukemia inhibitory factor
#101Compositions for biological systems and methods for preparing and using the same
#102Kappa myeloma antigen chimeric antigen receptors and uses thereof
#103TREATMENT OF CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND IL-6
#104Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#105COMPOSITION AND METHOD FOR INDUCING ANTI-INFLAMMATORY RESPONSE
#106Methods of delivering a pseudotyped lentivirus
#107METHODS AND COMPOSITIONS FOR THE TREATMENT OF EPIDERMOLYSIS BULLOSA
#108Vaccine formulation, preparation method therefor and use thereof
#109Combination of local rose bengal and systemic immunomodulative therapies for enhanced treatment of cancer
#110Method for treating chronic intestinal inflammation and inflammatory bowel disease by administering antagonists of Oncostatin-M (OSM) and/or antagonists of OSM receptor-beta (OSMR)
#111Treatment of right ventricular dysfunction due to pressure overload
#112Anti-IL-6 vaccine composition
#113Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
#114Human amniotic fluid preparation having long-term stability
#115Postpartum cells derived from placental tissue, and methods of making and using the same
#116Mannose-6-phosphate bearing peptides fused to lysosomal enzymes
#117Conditioned medium obtained from placental mesenchymal stem cells and use thereof in the therapeutic treatment of preeclampsia
#118USE OF PHOSPHORYLATION PATHWAY-RELATED FACTOR IN REGULATING FUNCTION OF REGULATORY T CELL
#119Conditioned medium of liver progenitor cells
#120Postpartum cells derived from placental tissue, and methods of making and using the same
#121Postpartum cells derived from placental tissue, and methods of making and using the same
#122Soft tissue repair and regeneration using postpartum-derived cells and cell products
#123COMPOSITIONS AND METHODS OF REGULATING BONE RESORPTION
#124Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3A/C4A, immunoglobulins and chemotactic factors
#125COMPOSITIONS AND METHODS FOR TREATING RETINOPATHY
#126HPV vaccines and methods of use thereof
#127Breast cancer vaccines and methods of use thereof
#128WOUND HEALING COMPOSITION
#129METHOD AND COMPOSITION FOR THE TREATMENT OF MODERATE TO SEVERE KERATOCONJUNCTIVITIS SICCA
#130Methods and compositions for inducing differentiation of human brown adipocyte progenitors
#131Recombinant retrovirus pseudotyped with E2 alphavirus glycoprotein
#132COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#133ENCAPSULATED STEM CELLS FOR THE TREATMENT OF INFLAMMATORY DISEASE
#134Method of immunotherapy for treatment of human papillomavirus infection
#135Compounds suitable for the treatment of myeloproliferative neoplasms as well as methods for the diagnosis/prognosis of myeloproliferative neoplasms
#136Re-directed immunotherapy
#137Activated leukocyte conditioned supernatant and uses for wound healing
#138Compositions and methods for treating and repairing tendons
#139Anti-IL-6 antibodies for the treatment of oral mucositis
#140Glaucoma treatment
#141Sgp130/Fc dimers
#142COMPOSITION COMPRISING A SINGLE VARIABLE DOMAIN AND CAMOSTAT MESYLATE (CM)
#143Spiro ring compound as hepatitis C virus (HCV) inhibitor and uses thereof
#144Hepatitis C virus inhibitors
#145Combination of local and systemic immunomodulative therapies for melanoma and liver cancer
#146Combination of rose bengal and systemic immunomodulative therapies for enhanced treatment of cancer
#147Hepatitis C virus inhibitors
#148Re-directed immunotherapy
#149Preeclamptic placental mesenchymal stem cell conditioned medium for use in the treatment of a tumour
#150Neurotherapeutic Nanoparticle Compositions and Devices
#151Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#152Generating hepatocytes
#153Systems and methods for angiogenic treatment in wound healing
#154Pharmaceutical composition having preventative or treatment effect on inflammatory bowel diseases
#155Methods for inducing migration by dendritic cells and an immune response
#156NOVEL SURFACE MARKERS FOR ADIPOSE TISSUE
#157Hepatitis C virus inhibitors
#158Anti-LAMP5 antibody and utilization thereof
#159Method for increasing the expression of anti-microbial peptides by keratinocytes comprising administering a composition comprising IL-17, TNF-alpha and OSM
#160Bioactive compositions and methods for their preparation and use
#161Bioactive compositions derivable from platelet concentrates, and methods for preparing and using same
#162Embryo implantation
#163Isolation and use of human lymphoid organ-derived suppressive stromal cells
#164CELLS, COMPOSITIONS, AND TREATMENT METHODS FOR STIMULATION OF HEMATOPOIESIS
#165Skin cream
#166CONDITIONED MEDIUM OBTAINED FROM PLACENTAL MESENCHYMAL STEM CELLS AND USE THEREOF IN THE THERAPEUTIC TREATMENT OF PREECLAMPSIA
#167Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3A/C4A, and chemotactic factors
#168Vaccine immunotherapy for treating cervical cancer in immune suppressed patients
#169Vaccine immunotherapy for treating lymphoma in immune suppressed patients
#170METHODS OF INHIBITING PHOTORECEPTOR APOPTOSIS
#171Method for treating chronic colitis and systemic sclerosis and for eliciting a protective immune reaction against human IL-6
#172Therapeutic agent for infections, and treatment method using same
#173Hepatitis C Virus Inhibitors
#174Compositions derived from stem cell released molecules and methods for formulation thereof
#175sgp130/Fc dimers for treatment of inflammatory disease
#176Hepatitis C virus inhibitors
#177Vaccine immunotherapy
#178Hepatitis C virus inhibitors
#179Vaccine immunotherapy for treating hepatocellular cancer in immune suppressed patients
#180VACCINE IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS
#181Re-directed immunotherapy
#182Moesin modulators and uses thereof
#183Compositions and methods for inducing migration by dendritic cells and an immune response
#184Vaccine immunotherapy
#185Methods for Treating Patients Undergoing Multi-Cycle Chemotherapy
#186Activated leukocyte conditioned supernatant and uses for wound healing
#187Sequential administration of a replication defective adenovirus vector in vaccination protocols
#188Mobilization of hematopoietic stem cells
#189Method for the prophylactic or therapeutic treatment of glucocorticoid-induced osteoporosis
#190Preparative regimen for engraftment, growth and differentiation of non-hematopoeitic cells in vivo after transplantation
#191Hepatitis C virus inhibitors
#192Tripeptides Incorporating Deuterium as Inhibitors of Hepatitis C Virus
#193Hepatitis C virus inhibitors
#194METHODS FOR TREATMENT OF MICROBIAL DISORDERS
#195Regeneration and repair of neural tissue using postpartum-derived cells
#196Therapeutic Agent for infections, and treatment method using the same
#197Hepatitis C virus inhibitors
#198COMPOSITIONS FOR THE TREATMENT OF INFECTIOUS AND TUMOURAL DISEASES
#199Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer
#200Method of immunotherapy for treament of human papillomavirus infection
#201Treating non-hematopoietic cancer with interleukin 6
#202Skin cream
#203Stem Cell Conditioned Medium Compositions
#204Anti-IL-6 antibodies for the treatment of oral mucositis
#205Treating cardiovascular tissue
#206RETRO-INVERSO PEPTIDES DERIVED FROM INTERLEUKIN-6
#207Method of identifying tumor associated antigens
#208COMPOSITIONS FOR PREVENTING, REDUCING OR TREATING KERATINOCYTE-MEDIATED INFLAMMATION
#209Anti-IL-6 antibodies for the treatment of anemia
#210TREATMENT OF ONCOSTATIN M RECEPTOR BETA MEDIATED HEART FAILURE
#211Stabilization of interleukin 6 in serum based solutions
#212Targeted gene delivery to dendritic cells
#213Vaccine immunotherapy
#214Bacterial ghosts for mediating innate immunity
#215Inhibiting non-hematopoietic cancer with interleukin 6
#216Method And Composition For The Treatment Of Moderate To Severe Keratoconjunctivitis Sicca
#217USE OF CARDIOTROPHIN-1 FOR THE TREATMENT OF METABOLIC DISEASES
#218CATABOLIC AGENTS
#219Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#220METHODS FOR TREATMENT OF MICROBIAL DISORDERS
#221IL6R/IL6 chimera for therapy of chemotherapy-induced peripheral neuropathy
#222METHODS AND MATERIALS FOR REDUCING OR SUPPRESSING AMYLOID DEPOSITION
#223TREATMENT OF ACUTE MYOCARDIAL INFARCTION (AMI) USING ENCAPSULATED CELLS ENCODING AND SECRETING GLP-1 PEPTIDES OR ANALOGS THEREOF
#224Combination pharmaceutical agents as inhibitors of HCV replication
#225ONCOSTATIN M AS PROMOTER OF IMMUNOSTIMULATORY ACTIVITY OF HUMAN EPITHELIAL CELLS
#226ORGANIC COMPOUNDS AND THEIR USES
#227Conditioned medium of liver progenitor cells
#228IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS
#229IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS
#230LIPOPOLYSACCHARIDE ISOLATED FROM PYRULARIA TISSUE AND/OR PYRULARIA-ASSOCIATED BACTERIA AND USES THEREOF
#231Enhanced ocular neuroprotection and neurostimulation
#232Method and compositions for prevention and treatment of diabetic and aged skin
#233Methods of suppressing microglial activation
#234Therapy of neurological inflammatory diseases with (5'-deoxy-5'-adenosyl) cobamamide, recombinant human growth hormone, interleukins IL-1, IL-6, IL-11, epidermal growth factor, and physiotherapy
#235Mobilization of hematopoietic stem cells
#236Cardioprotective role of hepatic cells and hepatocyte secretory factors in myocardial ischemia
#237THERAPEUTIC PREPARATIONS CONTAINING WHARTON'S JELLY
#238Hepatitis C virus inhibitors
#239VACCINE IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS
#240Retro-inverso peptides derived from interleukin-6
#241METHOD OF TREATING ERYTHROPOIETIN HYPORESPONSIVE ANEMIAS
#242Regeneration and repair of neural tissue using postpartum-derived cells
#243Methods of inhibiting photoreceptor apoptosis
#244Hepatitis C virus inhibitors
#245Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
#246Use of gp130 activators in diabetic neuropathy
#247Sequential administration of a replication defective adenovirus vector in vaccination protocols
#248Synergism Between Activated Immune Cells and Conventional Cancer Therapies
#249Use of IL-6/IL-6 chimera in Huntington's disease
#250Methods for the treatment of renal failure
#251Recombiant lentivirus comprising an E2 alphavirus glycoprotein that binds to DC-SIGN
#252Packaging cells for producing retrovirus pseudotyped with an E2 alphavirus glycoprotein
#253Vaccine immunotherapy
#254sgp130/Fc dimers
#255Method for promoting muscle regeneration by administering an antibody to the IL-6 receptor
#256MODULATORS OF CARDIAC CELL HYPERTROPHY AND HYPERPLASIA
#257COMPOSITIONS FOR PREVENTING, REDUCING OR TREATING KERATINOCYTE-MEDIATED INFLAMMATION
#258Therapeutic agent for infections, and treatment method using the same
#259STAT3 Agonists and Antagonists and Therapeutic Uses Thereof
#260Cancer Vaccines and Therapeutic Methods
#261Methods of Alleviating Disorders and Their Associated Pain
#262Compositions and methods for treatment of microbial disorders
#263Methods of suppressing microglial activation and systemic inflammatory responses
#264VACCINE IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS
#265METHODS OF SUPPRESSING MICROGLIAL ACTIVATION AND SYSTEMIC INFLAMMATORY RESPONSES
#266USE OF gp130 ACTIVATORS IN DIABETIC NEUROPATHY
#267Use of a Compound with RANKL Activity
#268Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#269ENHANCED RECOVERY FOLLOWING OCULAR SURGERY
#270Compositions for enhancing keratinocyte migration and epidermal repair via a receptor containing OSMRβ as a subunit, and applications thereof
#271Methods for attenuating virus strains for diagnostic and therapeutic uses
#272Therapeutic angiogenesis for treatment of the spine
#273Methods for Treatment and Prevention of Infection
#274Hepatitis C virus inhibitors
#275Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#276TREATMENTS OF B-CELL PROLIFERATIVE DISORDERS
#277CONDITIONED BLOOD COMPOSITION AND METHOD FOR ITS PRODUCTION
#278COMBINATION OF INTERLEUKIN-6 ANTAGONISTS AND ANTIPROLIFERATIVE DRUGS
#279Methods for hematopoietic stimulation
#280Method of treating or preventing tissue deterioration, injury or damage due to a neuro-, muscular- or neuro-muscular-degenerative disease, or restore tissue adversely affected by said disease
#281Method for Treating Neurological Disorders
#282PREPARATIVE REGIMEN FOR ENGRAFTMENT, GROWTH AND DIFFERENTIATION OF NON-HEMATOPOEITIC CELLS IN VIVO AFTER TRANSPLANTATION
#283Compositions consisting essentially of TGF-β, BMP-2 FGF-4, leukemia inhibitory factor, IGF-1, IL-6 and H-α-thrombin
#284Compositions and methods for therapy or prevention of chemotherapy-induced neuropathy
#285Compositions and methods for soft tissue repair
#286Methods of suppressing microglial activation
#287ENHANCED OCULAR NEUROPROTECTION AND NEUROSTIMULATION
#288Inhibitors of Hepatitis C Virus
#289Method for inhibiting a microvascular complication by administering IL-6
#290ENHANCED RECOVERY FOLLOWING OCULAR SURGERY
#291Method for detecting candidate alzheimer's disease drug
#292Compositions for modulating growth of embryonic and adult kidney tissue and uses for treating kidney damage
#293Homing of cells to myocardium
#294Use of IL-6 in liver injury
#295Targeted gene delivery for dendritic cell vaccination
#296Compositions and Methods for Treating Hypertension and Inflammation
#297REMEDIES FOR NERVE DAMAGES
#298Chemoprevention of endometrial cancer
#299Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors
#300Stem cells having increased sensitivity to a chemoattractant and methods of generating and using same